Histopathologic predictors of pilocytic astrocytoma event-free survival

被引:0
作者
Kathleen M. Tibbetts
Ryan J. Emnett
Feng Gao
Arie Perry
David H. Gutmann
Jeffrey Russell Leonard
机构
[1] Washington University School of Medicine,Department of Neurology
[2] Washington University School of Medicine,Department of Biostatistics
[3] Washington University School of Medicine,Division of Neuropathology, Department of Pathology and Immunology
[4] Washington University School of Medicine,Department of Neurosurgery
来源
Acta Neuropathologica | 2009年 / 117卷
关键词
Glioma; Pediatric; CD68; Microglia; Brain tumor; Pilocytic astrocytoma; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
Pilocytic astrocytoma (PA) is the most common pediatric brain tumor. Most arise in the cerebellum, but they also can develop in the brainstem and optic nerve, where gross total resection (GTR) is not possible. In the absence of GTR, significant variability in both clinical behavior and histology exists. To identify potential markers associated with poor clinical outcome, we retrospectively assessed pathological features in 107 patients with PAs. We identified four pathological features (necrosis, oligodendroglioma-like features, vascular hyalinization, and calcification) that showed a significant correlation with decreased event-free survival (EFS). Similar to previous reports, we also found that PAs involving the optic pathway were associated with worse EFS compared with those arising in other locations. In contrast, mitotic index, p53 immunoreactivity and hyperactivation of several mitogenic signaling pathways (MAPK, CREB, mTOR) did not demonstrate a statistically significant relationship with EFS. Lastly, we did find a statistical trend between EFS and the number of CD68+ cells, suggesting that non-neoplastic elements of the tumor microenvironment may influence subsequent growth and clinical recurrence. Collectively, the identification of specific histopathologic features associated with clinical outcome may improve our ability to determine which PAs are more likely to exhibit clinical progression and require more vigilant observation.
引用
收藏
相关论文
共 73 条
  • [1] Bowers DC(2003)Study of MIB-1 labelling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents J Clin Oncol 21 2968-2973
  • [2] Gargan L(2003)Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas Histopathology 37 437-444
  • [3] Kapur P(2007)Neurofibromatosis (NF1) heterozygous brain microglia elaborate paracrine factors that promote NF1-deficient astrocyte and glioma growth Hum Mol Genet 16 1098-1112
  • [4] Cheng Y(2008)Increased c-Jun-NH Cancer Res 68 10358-10366
  • [5] Pang JC-S(2008)-kinase signaling in neurofibromatosis-1 heterozygous microglia drives microglia activation and promotes optic glioma proliferation Anticancer Res 28 15-19
  • [6] Ng H-K(2003)Proliferation and programmed cell death: role of p53 protein in high and low grade astrocytoma Neurosurgery 53 544-555
  • [7] Daginakatte GC(2002)Pilocytic astrocytomas in children: prognostic factors—a retrospective study of 80 cases Int J Radiat Oncol Biol Phys 52 996-1001
  • [8] Gutmann DH(1997)Ki-67: a prognostic factor for low-grade glioma? J Clin Oncol 15 2792-2799
  • [9] Daginakatte GC(1989)Low-grade astrocytoma: a decade of experience at St. Jude Children’s Research Hospital J Neurosurg 71 661-664
  • [10] Giamino SM(1989)Astrocytomas of the cerebellum in children J Neurosurg 70 568-572